Associations of Commonly Used Medications with Urinary Incontinence in a Community Based Sample
- 1 July 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 188 (1) , 183-189
Abstract
We examined the association between the use of medications and the prevalence of urinary incontinence in gender specific analyses of a community based, representative sample. A population based epidemiological study was conducted of 5,503 men and women 30 to 79 years old residing in Boston, Massachusetts (baseline data collected from 2002 to 2005). Urological symptoms were ascertained in a 2-hour, in person interview. Urinary incontinence was defined as urine leakage occurring weekly or more often during the last year. Medications used in the last month were considered current use. Associations of 20+ medications and prevalent urinary incontinence were examined using multivariate logistic regression (ORs and 95% CIs) with adjustments for known urinary incontinence risk factors. The prevalence of urinary incontinence in the analysis sample was 9.0% in women and 4.6% in men. For women the prevalence was highest among users of certain antihistamines (28.4%) and angiotensin II receptor blockers (22.9%). For men the prevalence was highest among angiotensin II receptor blocker (22.2%) and loop diuretic (19.1%) users. After final multivariate adjustment there were significant positive associations for certain antihistamines, beta receptor agonists, angiotensin II receptor blockers and estrogens with urinary incontinence in women (all ORs greater than 1.7), and a borderline significant association for anticonvulsants (OR 1.75; 95% CI 1.00, 3.07). Among men only anticonvulsants were associated with urinary incontinence after final adjustments (OR 2.50; 95% CI 1.24, 5.03), although angiotensin II receptor blockers showed an adjusted association of borderline significance (OR 2.21; 95% CI 0.96, 5.10). Although a cross-sectional analysis cannot determine causality, our analysis suggests certain medications should be further examined in longitudinal analyses of risk to determine their influence on urological symptoms.Keywords
This publication has 24 references indexed in Scilit:
- Commonly used antihypertensives and lower urinary tract symptoms: results from the Boston Area Community Health (BACH) SurveyBJU International, 2011
- Prevalence and Trends of Urinary Incontinence in Adults in the United States, 2001 to 2008Journal of Urology, 2011
- The Effect of Medication Use on Urinary Incontinence in Community‐Dwelling Elderly WomenJournal of the American Geriatrics Society, 2010
- General exposures to prescription medications by race/ethnicity in a population‐based sample: results from the Boston Area Community Health SurveyPharmacoepidemiology and Drug Safety, 2010
- Oral Contraceptive Use and Incident Urinary Incontinence in Premenopausal WomenJournal of Urology, 2009
- Investigations into the presence of functional ß1, ß2 and ß3-adrenoceptors in urothelium and detrusor of human bladderInternational braz j urol, 2009
- Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) SurveyEuropean Urology, 2007
- NEW INSIGHTS INTO β‐ADRENOCEPTORS IN SMOOTH MUSCLE: DISTRIBUTION OF RECEPTOR SUBTYPES and MOLECULAR MECHANISMS TRIGGERING MUSCLE RELAXATIONClinical and Experimental Pharmacology and Physiology, 2005
- Effects of Estrogen With and Without Progestin on Urinary IncontinenceJAMA, 2005
- Postmenopausal Hormone Therapy and Risk of Developing Urinary IncontinenceObstetrics & Gynecology, 2004